Watch Ticker

Fractyl Health, Inc. Common Stock

Go to Fractyl Health, Inc. Common Stock Website

$1.37

-0.49 (-26.34%)

Live

Previous Close

$1.87

Day Range

$1.84 - $1.95

Previous Day Range

$1.766 - $1.92

Market Cap

$91.1 million USD

Day Vol.

4.9 million

Previous Day Vol.

111696

Currency

USD

Primary Exchange

None

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic sy...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions

Fractyl Health, a metabolic therapeutics company, will present new preclinical data on its Rejuva Smart GLP-1 pancreatic gene therapy platform at the American Diabetes Association's 85th Scientific Sessions. The platform aims to develop novel, disease-modifying therapies for obesity and type 2 diabetes.

Related tickers: GUTS.

Read Full Article

N/A - Fractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes

Fractyl Health has submitted the first module of its Clinical Trial Application (CTA) in Europe for RJVA-001, its gene therapy candidate for type 2 diabetes. The upcoming first-in-human study aims to evaluate the safety, tolerability, and early efficacy of this one-time, pancreas-targeted smart GLP-1 gene therapy.

Related tickers: GUTS.

Read Full Article

Trending Tickers

Please sign in to view